Valute / PCRX
PCRX: Pacira BioSciences Inc
26.67
USD
0.18
(0.67%)
Il tasso di cambio PCRX ha avuto una variazione del -0.67% per oggi. Durante la giornata, lo strumento è stato scambiato ad un minimo di 26.17 e ad un massimo di 26.95.
Segui le dinamiche di Pacira BioSciences Inc. Le quotazioni in tempo reale aiutano a reagire velocemente alle variazioni di mercato. Scorrendo tra i diversi timeframe, è possibile monitorare le tendenze e le dinamiche dei tassi di cambio di minuti, ore, giorni, settimane e mesi. Utilizza queste informazioni per prevedere i cambiamenti del mercato e prendere decisioni di trading consapevoli.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
PCRX News
- PharmaCorp Rx completes fourth pharmacy acquisition for $2.4 million
- Pacira (PCRX) Q2 Revenue Rises 1.7%
- Pacira earnings beat by $0.02, revenue fell short of estimates
- Here's What Key Metrics Tell Us About Pacira (PCRX) Q2 Earnings
- Pacira (PCRX) Tops Q2 Earnings Estimates
- Pacira Q2 2025 slides: Revenue growth accelerates, margins expand amid strategic progress
- Pacira BioSciences: Worth Pondering, Strong Balance Sheet (NASDAQ:PCRX)
- Pacira BioSciences announces workforce reduction and facility changes
- PharmaCorp to acquire Western Canada pharmacy for $2.4 million
- Pacira BioSciences Debuts Inspiring New Film Highlighting One Patient’s Journey to Pain Relief and Innovation in Care at BIO 2025
- Impax Small Cap Fund Q1 2025 Commentary (Mutual Fund:PXSAX)
- Pacira BioSciences Unveils Three-Year Clinical Data Following a Single Local Administration of Investigational Gene Therapy, PCRX-201, in Patients with Moderate-to-Severe Osteoarthritis of the Knee
- Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Grabar Law Office Investigates Claims on Behalf of Shareholders of Pacira Biosciences Inc. (PCRX)
- Pacira at RBC Conference: Strategic Growth and Gene Therapy Focus
- Pacira reports promising gene therapy data for knee osteoarthritis
- Pacira BioSciences soars 52% following InvestingPro’s October Fair Value alert
- Wolverine World Wide, Pacira BioSciences And Other Big Stocks Moving Higher On Monday - Beam Therapeutics (NASDAQ:BEAM), B2Gold (AMEX:BTG)
- Pacira BioSciences Remains A 'Buy' For Pain Management With The NOPAIN Act
- Pacira Settles Patent Dispute Over Exparel With Fresenius, Delays Pain Med' Generics Entry Until 2030, Stock Jumps - Pacira BioSciences (NASDAQ:PCRX)
- Marvell Technology, Nvidia, Tesla, Apple And Other Big Stocks Moving Higher On Tuesday - Apple (NASDAQ:AAPL), Applied Optoelectronics (NASDAQ:AAOI)
- After-hours movers: Broadcom, Levi, Human and more
- Pacira BioSciences stock surges on patent litigation settlement
- Impax Small Cap Fund Q4 2024 Commentary
Intervallo Giornaliero
26.17
26.95
Intervallo Annuale
12.62
27.64
- Chiusura Precedente
- 26.85
- Apertura
- 26.90
- Bid
- 26.67
- Ask
- 26.97
- Minimo
- 26.17
- Massimo
- 26.95
- Volume
- 1.428 K
- Variazione giornaliera
- -0.67%
- Variazione Mensile
- 26.46%
- Variazione Semestrale
- 11.36%
- Variazione Annuale
- 74.31%
31 agosto, domenica